SCHEMBL14425317

SCHEMBL14425317

O=C(NC[C@@H]1CN(C(=O)OCc2ccccc2)CCO1)c1ccc(O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
ENPP2 Q13822 2/20 0.48
F2 P00734 1/20 0.47
PLG P00747 1/20 0.47
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
TPSAB1 Q15661 1/20 0.47
TPSD1 Q9BZJ3 1/20 0.47
TPSG1 Q9NRR2 1/20 0.47
HPGD P15428 3/20 0.46
USP30 Q70CQ3 1/20 0.46
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14425436 1.00 MEN1 (0.50) MEN1KMT2ANPSR1ENPP2F2
SCHEMBL5368740 1.00 MEN1 (0.50) MEN1KMT2ANPSR1ENPP2F2
SCHEMBL14425361 0.94 F2 (0.46) MEN1KMT2ANPSR1ENPP2F2
SCHEMBL5366862 0.94 F2 (0.46) MEN1KMT2ANPSR1ENPP2F2
SCHEMBL14425362 0.94 HPGD (0.52) MEN1KMT2ANPSR1ENPP2F2
SCHEMBL5364667 0.94 HPGD (0.52) MEN1KMT2ANPSR1ENPP2F2
SCHEMBL5358920 0.91 ESR1 (0.47) MEN1KMT2ANPSR1ENPP2HPGD
SCHEMBL5370633 0.91 F2 (0.53) MEN1KMT2ANPSR1F2PLG
SCHEMBL14425466 0.91 F2 (0.53) MEN1KMT2ANPSR1F2PLG
SCHEMBL14425467 0.91 F2 (0.53) MEN1KMT2ANPSR1F2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed
US-7259157-B2 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists MERCK & CO., INC. (US) 2007-08-21 US disclosed